BBOTVSNFE• 6 Months (Normalized)
BBOT vs NFE (BridgeBio Oncology Therapeutics Inc. vs New Fortress Energy Inc.)
Showing Closing Date Range from Apr 8 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-54.98%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
NFE Performance $6.57
+887.97%
New Fortress Energy Inc.
Normalized Baseline0.00%
Alpha Spread Margin NFE LEADS
-942.95 pts
NFE outperforming by 942.95 percentage points
BBOTNFE
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT NFE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | BBOT Price | BBOT Gain (%) | NFE Price | NFE Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -54.98% | $6.57 | +887.97% | -942.95% |
| Oct 01, 2026 | $- | $5.91 | +788.72% | - | |
| Sep 30, 2026 | $4.10 | -52.55% | $6.27 | +842.86% | -895.41% |
| Sep 29, 2026 | $3.92 | -54.63% | $6.08 | +814.29% | -868.92% |
| Sep 28, 2026 | $3.81 | -55.90% | $6.48 | +874.44% | -930.34% |
| Sep 25, 2026 | $3.95 | -54.28% | $- | - | |
| Sep 24, 2026 | $3.99 | -53.82% | $- | - | |
| Sep 23, 2026 | $4.16 | -51.85% | $6.40 | +862.41% | -914.26% |
| Sep 22, 2026 | $4.66 | -46.06% | $8.15 | +1125.56% | -1171.62% |
| Sep 21, 2026 | $4.66 | -46.06% | $10.82 | +1527.07% | -1573.13% |
| Sep 18, 2026 | $4.77 | -44.79% | $12.22 | +1737.59% | -1782.38% |
| Sep 17, 2026 | $4.89 | -43.40% | $12.41 | +1766.17% | -1809.57% |
| Sep 16, 2026 | $4.76 | -44.91% | $12.51 | +1781.20% | -1826.11% |
| Sep 15, 2026 | $4.88 | -43.52% | $12.77 | +1820.30% | -1863.82% |
| Sep 14, 2026 | $5.05 | -41.55% | $13.88 | +1987.22% | -2028.77% |
Page 1 of 9